From The Editor-In-Chief
Emerging insights into epigenetic abnormalities in cancer cells may lead to better cancer outcomes.
by William G. Nelson, MD, PhD
Getting Help to Avoid Financial Distress | Cryoablation May Be a Treatment Option for Some Patients | Makers of E-Cigarettes Tout Role in Smoking Cessation | More Options to Prevent Blood Clots in High-Risk Cancer Patients | New Guidelines for Radiation Therapy in Pancreatic Cancer | Managing Opioid-Related Constipation | What’s Next
YOUR CANCER GUIDE
Patients with metastatic disease need to carefully consider risks and benefits of therapies within the context of their goals.
by Hester Hill Schnipper
CAREGIVING WITH CONFIDENCE
When families work together to provide care for a loved one, communicating can become a challenge.
by Ashley Jones
Cancer outcomes are changing for the better, but advances are not affecting all patients equally.
by Brian Rivers, PhD
A gene-editing tool called CRISPR holds promise for treating cancer. What does the new technology mean for patients?
by Stephen Ornes
Mark Good uses every avenue to spread the news about prostate cancer.
by Lindsey Konkel
Pancreatic cancer remains a difficult disease to treat and is expected to be the second leading cause of U.S. cancer-related deaths by 2030. Researchers hope clinical trials and insights into the genetics of the disease will reverse the trend.
by Kendall K. Morgan
Advocacy in Action
Two mothers, each with a son who died of brain cancer, worked together to increase awareness and acceptance of tumor tissue donation.
by Esther Landhuis
Go With Your Gut | The ABCs of CBD
Science writer Charles Graeber describes how a shift in researchers’ understanding of immune function and cancer is leading to effective treatments.
by Marci A. Landsmann
Experts offer advice on getting involved with patient advocacy, expressing feelings to loved ones, and hospice care.
A mother whose son was diagnosed with Burkitt leukemia works to improve access to mental health services for teenagers.
by Elizabeth Rosto Sitko
Readers share snapshots of their lives today.
Survival statistics are important—and sometimes confusing. Cancer Today spoke with statistics experts about what these numbers really mean.
by Ashley P. Taylor
Scientists and physicians discussed advances in targeted therapies and immunotherapies, as well as the lessons COVID-19 research has taught to cancer researchers.
by Kevin McLaughlin
Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.
by Marcus A. Banks
Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions.
by Anna Goshua
The AACR led a contingent of 130 organizations in asking that cancer patients and survivors be granted high priority in receiving COVID-19 vaccinations.
Eliminating disparities requires consistent effort on numerous fronts, including the development and sustenance of a diverse scientific workforce.
In March of last year, screenings for breast, colon and cervical cancer decreased by roughly 90% compared with historical rates.
Learning Medicare’s ABCDs
donate to the AACR